The Neuroendocrine Tumor Treatment Global Market Report 2023, provides comprehensive information on the neuroendocrine tumor treatment market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Neuroendocrine Tumor Treatment Market’s Growth:
https://www.thebusinessresearchcompany.com/report/neuroendocrine-tumor-treatment-global-market-report
The global neuroendocrine tumor treatment market is expected to grow from $1.73 billion in 2022 to $1.94 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global neuroendocrine tumor treatment is expected to reach $2.88 billion in 2027 at a CAGR of 10.5%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12248&type=smp
Clinical drug development for treatment is a key trend gaining popularity in the neuroendocrine tumor treatment market. Major companies operating in the neuroendocrine tumor treatment market are developing innovative therapies to sustain their position in the market. For instance, in October 2022, Viewpoint Molecular Targeting, Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA), a US-based federal agency, has granted fast-track designation for the development of [212Pb] VMT-a-NET for the treatment of patients with SSTR2-positive unresectable or metastatic neuroendocrine tumors (NETs). VMT-a-NET is a targeted alpha-particle therapy (TAT) designed to kill cancer cells that selectively express somatostatin receptors. The FDA’s fast-track designation is intended to expedite the development and review of [212Pb] VMT-a-NET for treating NETs. This designation is given to drugs that have the potential to provide a significant improvement in the safety or effectiveness of treatment for a severe condition.
The neuroendocrine tumor treatment market is segmented:
1) By Product: Somatostatin Analogs (SSAs), Targeted Therapy, Chemotherapy, Others Products
2) By Indication: Lungs, Pancreas, Gastrointestinal, Others Indications
3) By End-Users: Hospitals, Oncology Centers, Other End-Users
North America was the largest region in the neuroendocrine tumor treatment market in 2022.
The table of contents in TBRC’s neuroendocrine tumor treatment market report includes:
1. Executive Summary
2. Neuroendocrine Tumor Treatment Market Characteristics
3. Neuroendocrine Tumor Treatment Market Trends And Strategies
4. Neuroendocrine Tumor Treatment Market – Macro Economic Scenario
6. Neuroendocrine Tumor Treatment Market Segmentation
……..
32. Global Neuroendocrine Tumor Treatment Market Competitive Benchmarking
33. Global Neuroendocrine Tumor Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Neuroendocrine Tumor Treatment Market
35. Neuroendocrine Tumor Treatment Market Future Outlook and Potential Analysis
36. Appendix
Top Major Players:
Pfizer Inc.
F Hoffmann-La Roche AG
AbbVie Inc.
Novartis AG, Sanofi SA
Bristol-Myers Squibb Company
Related Reports:
https://topprnews.com/artificial-intelligence-software-as-a-service-saas-market-trends/
https://topprnews.com/green-chemicals-market-trends/
https://topprnews.com/industrial-automation-oil-and-gasmarket-analysis/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
